April 24, 2024 14:27 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Centre moves Supreme Court seeking modification of 2012 verdict in 2G spectrum case | 'Robert Vadra Ab Ki Baar' posters in Amethi as suspense looms over Congress candidate | Sam Pitroda's comment on wealth distribution stirs row, Congress distances itself, Amit Shah says 'party exposed' | Renowned dancer and ex-professor at Chennai academy arrested on sexual harassment charges | 'Has anyone robbed your mangalsutra during Congress rule?' Priyanka Gandhi counters PM's charge
Dr Reddy's Laboratories to launch Testosterone Gel

Dr Reddy's Laboratories to launch Testosterone Gel

India Blooms News Service | @indiablooms | 06 May 2019, 12:15 pm

Mumbai, May 6 (UNI) Pharma Major, Dr Reddy's Laboratories Ltd on Monday announced the launch of Testosterone Gel 1.62 pc, a therapeutic equivalent generic version of AndroGel (testosterone gel) 1.62 pc, approved by the US Food and Drug Administration (USFDA).

The AndroGel (testosterone gel) brand and generic had US sales of approximately USD 815.6 million MAT for the most recent twelve months ending in February 2019 according to IQVIA Health, company said in a filing with BSE.

Dr Reddy's Testosterone Gel 1.62 pc (20.25 mg/1.25 g pump actuation) is available in a net quantity of 88 g pump which dispenses 20.25 mg of testosterone per actuation.

Each metered-dose pump is capable of dispensing 60 metered pump actuation. 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.